Published in Am J Surg on April 01, 1986
Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ (1998) 2.58
Ambulatory surgical management of breast carcinoma using paravertebral block. Ann Surg (1995) 1.62
The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. Ann Surg (1992) 1.49
Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg (1998) 1.43
Early removal of drains and discharge of breast cancer surgery patients: a controlled prospective clinical trial. Ann R Coll Surg Engl (1995) 1.17
Economic impact of reducing hospitalization for mastectomy patients. Ann Surg (1988) 1.12
Seroma with fibrous capsule formation requiring a surgical resection after a modified radical mastectomy: report of a case. Surg Today (1998) 0.86
Does LigaSure reduce fluid drainage in axillary dissection? A randomized prospective clinical trial. Ecancermedicalscience (2007) 0.78
Comparisons of single-injection thoracic paravertebral block with ropivacaine and bupivacaine in breast cancer surgery: A prospective, randomized, double-blinded study. Anesth Essays Res (2016) 0.75
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol (2007) 7.33
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA (1994) 4.01
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA (2000) 3.18
Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum (2004) 3.12
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. Br J Anaesth (2000) 2.56
A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg (1996) 2.49
Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery (1970) 2.34
Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res (2000) 2.34
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys (1990) 2.11
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
A novel alpha-type carbonic anhydrase associated with the thylakoid membrane in Chlamydomonas reinhardtii is required for growth at ambient CO2. EMBO J (1998) 2.01
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol (1992) 1.98
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgment. Am J Med (1990) 1.93
Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A (1997) 1.88
Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer (1983) 1.87
Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86
Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg (1999) 1.84
Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol (2000) 1.83
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol (2001) 1.83
Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res (1991) 1.77
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Secretion of collagen by embryonic neuroepithelium at the time of spinal cord--somite interaction. Dev Biol (1971) 1.69
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol (1999) 1.68
High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr (1993) 1.64
Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62
Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg (1994) 1.61
Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg (1997) 1.61
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A (1992) 1.60
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol (2000) 1.54
Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg (1996) 1.52
Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg (1999) 1.51
In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 1.50
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J (1990) 1.48
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci U S A (1995) 1.47
Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer (1992) 1.45
Urinary diversion after total pelvic exenteration for rectal cancer. Ann Surg Oncol (1999) 1.44
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol (1996) 1.43
Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Cancer (1980) 1.42
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum (1997) 1.41
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis (1999) 1.41
Failure patterns following curative resection of colonic carcinoma. Ann Surg (1984) 1.39
Adjuvant external beam and intraoperative radiation therapy in rectal cancer. Cancer Invest (1989) 1.39
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol (1996) 1.39
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg (1997) 1.38
Carcinoid tumors of the appendix. Ann Surg (1993) 1.36
Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am J Hum Genet (1996) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol (1991) 1.32
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum (2000) 1.32
Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg (1991) 1.30
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2001) 1.30
Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1984) 1.30
Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res (1995) 1.29
Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol (1988) 1.29
Studies of dormant tumor cells. Cancer (1971) 1.28
Cardiovascular actions of berberine. Cardiovasc Drug Rev (2001) 1.28
Pharmacokinetic interaction trial between co-artemether and mefloquine. Eur J Pharm Sci (2000) 1.27
A clonal approach to the problem of neural crest determination. Dev Biol (1975) 1.27
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26
Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol (1991) 1.26
Long-term outcomes of deep-vein thrombosis. Arch Intern Med (1995) 1.26
Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology (1986) 1.26
The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J (1989) 1.25
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24
p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. J Clin Oncol (1994) 1.22
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol (1992) 1.22
Clonal analysis of quail neural crest cells: they are pluripotent and differentiate in vitro in the absence of noncrest cells. Dev Biol (1980) 1.21
Characterization and biological effects of recombinant human erythropoietin. Immunobiology (1986) 1.20
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol (1996) 1.20
Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys (1998) 1.20
Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum (1999) 1.20
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg (1999) 1.18
Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg (1998) 1.17
Factors directing the expression of sympathetic nerve traits in cells of neural crest origin. J Exp Zool (1972) 1.17
Isolation of cDNA clones of genes induced upon transfer of Chlamydomonas reinhardtii cells to low CO2. Plant Mol Biol (1996) 1.16
Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Cancer (1985) 1.15
Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg (1994) 1.15
Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin (1995) 1.15
Arteriographic findings in congenital transmesenteric internal hernia. AJR Am J Roentgenol (1979) 1.14
Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology (2001) 1.14
Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci (1993) 1.13
All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum (1999) 1.12
Preoperative radiation therapy for sarcoma of soft tissue. Cancer (1981) 1.12
Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer (1991) 1.11
Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg (1984) 1.11